Wed, Jan 20
|ONLINE
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Time & Location
Jan 20, 2021, 7:00 p.m. – 9:00 p.m. EST
ONLINE
About the Event
CHEP+ Clinical Practice Guidelines Program
Anticoagulation in Nonvalvular Atrial Fibrillation in Patients with Renal Disease
Wed January 20, 2021, • 7:00-9:00 PM ET
Presented by: Dr. Sheldon Tobe MD, FRCPC, MScCH (HPTE), FACP, FAHA
Dr. Tobe is a specialist in Hypertension and Nephrology, Division of Nephrology, Sunnybrook Health Sciences Centre, and is the University of Toronto Postgraduate Fellowship Director – Nephrology. He is a Professor in the Faculty of Medicine, University of Toronto and Northern Ontario School of Medicine (NOSM).
LEARNING OBJECTIVES
Upon completion of this case study, participants should be able to:
- Describe the rationale for anticoagulation of non-valvular atrial fibrillation
- Describe the effect on outcomes of non-valvular atrial fibrillation with CKD
- Describe the management of patients with CKD and non-valvular atrial fibrillation
Accreditation: This Group Learning program has been certified by the Canadian College of Family Physicians for up to 6 Mainpro+ credits for the 2-hour presentation including a practice reflection survey to be completed at 6 weeks post-session.